Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Gilead begins phase I study of adefovir dipivoxil in China for treatment of HBV

June 13, 2001

NOD2 mutants associated with Crohn's disease

June 8, 2001

Phytopharmaceutical DA-9601 prevents development of pancreatic fibrosis

June 8, 2001

GM-611 improves delayed gastric emptying in patients with gastroparesis

June 8, 2001

Zelmac regulatory application voluntarily withdrawn in E.U.

June 5, 2001

Solid dosage form of antibody for UC to be developed by KS Biomedix and MedPharm

May 30, 2001

DDW presentations describe pharmacological profile of Z-360, a new gastrin antagonist

May 29, 2001

Rapid and sustained symptom relief experienced by majority of IBS patients on tegaserod

May 29, 2001

Novel TNF-alpha inhibitor prevents liver failure, promotes liver regeneration following HTx

May 28, 2001

CAPE efficacy in rat model of colitis attributed to inhibition of NF-kB

May 25, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...